Primary Biliary Cholangitis Trial, Recruiting (NCT04753996)

Primary Biliary Cholangitis Trial, Recruiting NCT04753996 Sponsor: Mayo Clinic Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT04753996 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults with PSC (a liver condition called Primary Sclerosing Cholangitis) who are between 18 and 85 years old.
People whose PSC diagnosis has been confirmed through blood tests, imaging of the bile ducts, and/or a liver biopsy showing signs of the condition lasting at least 6 months.
Women with PSC who are of childbearing age or who are pregnant may also be eligible to join.
People with both PSC and a bile duct cancer called Cholangiocarcinoma may also be eligible.
Healthy volunteers (used as comparison participants) between the ages of 18 and 85 who do not have PSC or any other long-term liver disease are also eligible to join.

Who may not be able to join:

People who are unable to give their own consent to participate in the study.
People who are currently in prison or living in an institution.
People with PSC who have already had a liver transplant.
People who have previously had a specific type of bowel surgery called a Roux-en-Y procedure (confirm with trial site if you are unsure whether this applies to you).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Konstantinos Lazaridis, MD, Mayo Clinic

Phone: (507) 284-4212

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04753996

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Primary Biliary Cholangitis

Trial contact: (507) 284-4212

More information: https://clinicaltrials.gov/study/NCT04753996

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults with PSC (a liver condition called Primary Sclerosing Cholangitis) who are between 18 and 85 years old.
People whose PSC diagnosis has been confirmed through blood tests, imaging of the bile ducts, and/or a liver biopsy showing signs of the condition lasting at least 6 months.
Women with PSC who are of childbearing age or who are pregnant may also be eligible to join.
People with both PSC and a bile duct cancer called Cholangiocarcinoma may also be eligible.
Healthy volunteers (used as comparison participants) between the ages of 18 and 85 who do not have PSC or any other long-term liver disease are also eligible to join.

Who may not be able to join:

People who are unable to give their own consent to participate in the study.
People who are currently in prison or living in an institution.
People with PSC who have already had a liver transplant.
People who have previously had a specific type of bowel surgery called a Roux-en-Y procedure (confirm with trial site if you are unsure whether this applies to you).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

8 March 2021

Est. completion

1 January 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants in study.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov